Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops - Investor's Business Daily

1. Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops  Investor's Business Daily
2. At $2 million, priciest ever medicine treats fatal genetic disease  NBC4i.com
3. Novartis launches most expensive drug ever for US$2.1 million  South China Morning Post
4. Newly approved gene therapy for SMA is based on delivery vehicle discovered by Penn expert  News-Medical.net
5. Novartis gets US approval for $2.1 million gene therapy  DAWN.com
6. View full coverage on Google News

from Health - Latest - Google News http://bit.ly/2YMegPA